OncologyConsults






All Modules

A Focus on Supportive Care:
Strategies to Improve Nausea and Vomiting in Cancer Patients
CME Credits: 0.5
Chemotherapy-induced nausea and vomiting (CINV) is a serious problem that can negatively impact a cancer patient’s quality of life and affect the timely deliver and ability to give the most effective doses of the chemotherapy treatment.
Faculty: Susan Urba, MD Expires: 11/19/2018


Appropriate Use of Immune Therapy to Treat Head and Neck Cancer CME Credits: 0.5
While the introduction of cetuximab for treating patients with head and neck carcinomas may have introduced another agent to oncologists, these agents (that target oncogenes) have not yielded a prolonged clinical benefit.
Faculty: David S. Ettinger, MD Expires: 9/7/2018


Considerations for Using Immune Therapy in Treating Metastatic Non-Small Cell Lung Cancer CME Credits: 0.5
Recent advances in immune therapy for patients with non-small cell lung cancer (NSCLC) have taken a long-awaited step forward and shifted the standard of care of patients with advanced and metastatic disease.
Faculty: David S. Ettinger, MD Expires: 11/19/2018


Metastatic Melanoma: Managing Benefit and Risk with the New Systemic Therapies CME Credits: 0.5
Melanoma is one of the most lethal human cancers and has historically been among the most resistant to contemporary chemotherapeutic approaches. It is the most serious form of skin cancer and has the highest mortality rate of all skin cancer types, leading to a rapid decline in the health in people who often are in the prime of life.
Faculty: William Sharfman, MD, FACP Expires: 5/20/2018